Biobijou Co Ltd
489460
Company Profile
Business description
Biobijou Co Ltd is engaged in the development, manufacturing, and distribution of medical aesthetic products. It offers a comprehensive range of medical aesthetic products designed for professional use such as Hyaluronic Acid (HA) Dermal Fillers, Skin Boosters, Botulinum Toxin, Lipolysis Injections and others.
Contact
947 Hanam-daero
Building A, Room 1516
U1CENTER, Hanam Techno Valley, Pungsan-dong
Gyeonggi-do
Hanam-si
KORT: +82 262359696
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
37
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks
Bapcor is paying for the sins of its past
Shares plunged over 17% after reporting disappointing results.
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,390.10 | 16.40 | 0.17% |
| CAC 40 | 8,224.55 | 18.48 | 0.23% |
| DAX 40 | 24,244.32 | 14.48 | -0.06% |
| Dow JONES (US) | 46,706.58 | 515.97 | 1.12% |
| FTSE 100 | 9,423.83 | 20.26 | 0.22% |
| HKSE | 26,027.55 | 168.72 | 0.65% |
| NASDAQ | 22,990.54 | 310.57 | 1.37% |
| Nikkei 225 | 49,316.06 | 130.56 | 0.27% |
| NZX 50 Index | 13,377.85 | 32.89 | 0.25% |
| S&P 500 | 6,735.13 | 71.12 | 1.07% |
| S&P/ASX 200 | 9,094.70 | 18.80 | 0.21% |
| SSE Composite Index | 3,916.33 | 52.44 | 1.36% |